2,238
Views
20
CrossRef citations to date
0
Altmetric
Brief Report

Nonspecificity in a nonimmune human scFv repertoire

, , &
Pages 1029-1035 | Received 13 Apr 2017, Accepted 11 Jul 2017, Published online: 18 Sep 2017

References

  • Wu H, Pfarr DS, Tang Y, An LL, Patel NK, Watkins JD, Huse WD, Kiener PA, Young JF. Ultra-potent antibodies against respiratory syncytial virus: Effects of binding kinetics and binding valence on viral neutralization. J Mol Biol. 2005;350:126-44. https://doi.org/10.1016/j.jmb.2005.04.049. PMID:15907931.
  • Datta-Mannan A, Lu J, Witcher DR, Leung D, Tang Y, Wroblewski VJ. The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies. MAbs. 2015;7:1084-93. https://doi.org/10.1080/19420862.2015.1075109. PMID:26337808.
  • Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity. 2007;26:205-13. https://doi.org/10.1016/j.immuni.2007.01.009. PMID:17306569.
  • Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med. 1994;180:885-95. https://doi.org/10.1084/jem.180.3.885. PMID:8064239.
  • Aguilera I, Melero J, Nuñez-Roldan A, Sanchez B. Molecular structure of eight human autoreactive monoclonal antibodies. Immunology. 2001;102:273-80. https://doi.org/10.1046/j.1365-2567.2001.01159.x. PMID:11298825.
  • West AP, Scharf L, Scheid JF, Klein F, Bjorkman PJ, Nussenzweig MC. Structural Insights on the role of antibodies in HIV-1 vaccine and therapy. Cell. 2014;156:633-48. https://doi.org/10.1016/j.cell.2014.01.052. PMID:24529371.
  • Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science. 2003;301:1374-7. https://doi.org/10.1126/science.1086907. PMID:12920303.
  • Mouquet H, Nussenzweig MC. Polyreactive antibodies in adaptive immune responses to viruses. Cell Mol Life Sci. 2012;69:1435-45. https://doi.org/10.1007/s00018-011-0872-6. PMID:22045557.
  • Birtalan S, Fisher RD, Sidhu SS. The functional capacity of the natural amino acids for molecular recognition. Mol Biosyst. 2010;6:1186-94. https://doi.org/10.1039/b927393j. PMID:20383388.
  • Birtalan S, Zhang Y, Fellouse FA, Shao L, Schaefer G, Sidhu SS. The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J Mol Biol. 2008;377:1518-28. https://doi.org/10.1016/j.jmb.2008.01.093. PMID:18336836.
  • Feldhaus MJ, Siegel RW, Opresko LK, Coleman JR, Feldhaus JMW, Yeung YA, Cochran JR, Heinzelman P, Colby D, Swers J, et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat Biotechnol. 2003;21:163-70. https://doi.org/10.1038/nbt785. PMID:12536217.
  • Prassler J, Thiel S, Pracht C, Polzer A, Peters S, Bauer M, Nörenberg S, Stark Y, Kölln J, Popp A, et al. HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J Mol Biol. 2011;413:261-78. https://doi.org/10.1016/j.jmb.2011.08.012. PMID:21856311.
  • Tiller T, Schuster I, Deppe D, Siegers K, Strohner R, Herrmann T, Berenguer M, Poujol D, Stehle J, Stark Y, et al. A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties. MAbs. 2013;5:1-26. https://doi.org/10.4161/mabs.24218. PMID:23254906.
  • Knappik A, Ge L, Honegger A, Pack P, Fischer M, Wellnhofer G, Hoess A, Wölle J, Plückthun A, Virnekäs B. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol. 2000;296:57-86. https://doi.org/10.1006/jmbi.1999.3444. PMID:10656818.
  • Wu H, Pfarr D, Johnson S, Brewah Y, Woods R, Patel N, White W, Young J, Kiener P. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol. 2007;368:652-65. https://doi.org/10.1016/j.jmb.2007.02.024. PMID:17362988.
  • Hotzel I, Theil FP, Bernstein LJ, Prabhu S, Deng R, Quintana L, Lutman J, Sibia R, Chan P, Bumbaca D, et al. A strategy for risk mitigation of antibodies with fast clearance. MAbs. 2012;4:753-60. https://doi.org/10.4161/mabs.22189. PMID:23778268.
  • Xu Y, Roach W, Sun T, Jain T, Prinz B, Yu TY, Torrey J, Thomas J, Bobrowicz P, Vásquez M, et al. Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: A FACS-based, high-throughput selection and analytical tool. Protein Eng Des Sel. 2013;26:663-70. https://doi.org/10.1093/protein/gzt047. PMID:24046438.
  • Kelly RL, Sun T, Jain T, Caffry I, Yu Y, Cao Y, Lynaugh H, Brown M, Vásquez M, Wittrup KD, et al. High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice. MAbs. 2015;7:770-7. https://doi.org/10.1080/19420862.2015.1043503. PMID:26047159.
  • Brezinschek H, Foster S. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5 (+)/IgM+ and CD5 (−)/IgM+ B cells. J Clin … 1997;99:2488-501. https://doi.org/10.1172/JCI119433. PMID:9153293.
  • Sivasubramanian A, Sircar A, Chaudhury S, Gray JJ. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins. 2009;74:497-514. https://doi.org/10.1002/prot.22309. PMID:19062174.
  • Lyskov S, Chou FC, Conchúir SÓ, Der BS, Drew K, Kuroda D, Xu J, Weitzner BD, Renfrew PD, Sripakdeevong P, et al. Serverification of molecular modeling applications: The Rosetta Online Server That Includes Everyone (ROSIE). PLoS One. 2013;8:5-7. https://doi.org/10.1371/journal.pone.0063906. PMID:23717507.
  • Marze NA, Lyskov S, Gray JJ. Improved prediction of antibody VL-VH orientation. Protein Eng Des Sel. 2016;29:409-18. https://doi.org/10.1093/protein/gzw013. PMID:27276984.
  • Datta-Mannan A, Thangaraju A, Leung D, Tang Y, Witcher DR, Lu J, Wroblewski VJ, Derrick R, Lu J, Wroblewski VJ. Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics. MAbs. 2015;7:483-93. https://doi.org/10.1080/19420862.2015.1016696. PMID:25695748.
  • Boswell CA, Tesar DB, Mukhyala K, Theil FP, Fielder PJ, Khawli L a. Effects of charge on antibody tissue distribution and pharmacokinetics. Bioconjug Chem. 2010;21:2153-63. https://doi.org/10.1021/bc100261d. PMID:21053952.
  • Hong G, Chappey O, Niel E, Scherrmann JM. Enhanced cellular uptake and transport of polyclonal immunoglobulin G and Fab after their cationization. J Drug Target. 2000;8:67-77. https://doi.org/10.3109/10611860008996853. PMID:10852339.
  • Van Es JH, Raaphorst FM, van Tol MJ, Meyling FH, Logtenberg T. Expression pattern of the most JH-proximal human VH gene segment (VH6) in the B cell and antibody repertoire suggests a role of VH6-encoded IgM antibodies in early ontogeny. J Immunol. 1993;150:161-8. PMID:8417121.
  • Cuisinier AM, Guigou V, Boubli L, Fougereau M, Tonnelle C. Preferential expression of VH5 and VH6 immunoglobulin genes in early human B-cell ontogeny. Scand J Immunol. 1989;30:493-7. https://doi.org/10.1111/j.1365-3083.1989.tb02455.x. PMID:2814367.
  • Berman JE, Nickerson KG, Pollock RR, Barth JE, Schuurman RK, Knowles DM, Chess L, Alt FW. VH gene usage in humans: Biased usage of the VH6 gene in immature B lymphoid cells. Eur J Immunol. 1991;21:1311-4. https://doi.org/10.1002/eji.1830210532. PMID:1903708.
  • Tiumentseva M, Morozova V, Zakabunin A, Korobko D, Malkova N, Filipenko M, Tikunova N. Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis. Immunogenetics. 2016;68:237-46. https://doi.org/10.1007/s00251-015-0895-5. PMID:26743536.
  • Tyumentseva MA, Morozova VV, Lebedev LR, Babkin IV, Tikunova NV. Presence of aberrant VH6 domains in anti-interferon-γ autoantibodies in multiple sclerosis. Hum Antibodies. 2013;22:31-49. doi:10.3233/HAB-130269. PMID:24284307.
  • Logtenberg T, Young FM, van Es J, Gmelig-Meyling FH, Berman JE, Alt FW. Frequency of VH-gene utilization in human EBV-transformed B-cell lines: The most JH-proximal VH segment encodes autoantibodies. J Autoimmun. 1989;2 Suppl:203-13. https://doi.org/10.1016/0896-8411(89)90132-7. PMID:2550019.
  • van Dijk-Hard I, Feld S, Holmberg D, Lundkvist I. Increased utilization of the VH6 gene family in patients with autoimmune idiopathic thrombocytopenic purpura. J Autoimmun. 1999;12:57-63. https://doi.org/10.1006/jaut.1998.0257. PMID:10028023.
  • Chukwuocha RU, Hsiao ET, Shaw P, Witztum JL, Chen PP. Isolation, characterization and sequence analysis of five IgG monoclonal anti-beta 2 glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display. J Immunol. 1999;163:4604-11. PMID:10510405.
  • Logtenberg T, Young FM, Van Es JH, Gmelig-Meyling FH, Alt FW. Autoantibodies encoded by the most Jh-proximal human immunoglobulin heavy chain variable region gene. J Exp Med. 1989;170:1347-55. https://doi.org/10.1084/jem.170.4.1347. PMID:2507728.
  • Kallewaard NL, Corti D, Collins PJ, Neu U, McAuliffe JM, Benjamin E, Wachter-Rosati L, Palmer-Hill FJ, Yuan AQ, Walker PA, et al. Structure and function analysis of an antibody recognizing all influenza a subtypes. Cell. 2016;166:596-608. https://doi.org/10.1016/j.cell.2016.05.073. PMID:27453466.
  • Andris JS, Brodeur BR, Capra JD. Molecular characterization of human antibodies to bacterial antigens: Utilization of the less frequently expressed VH2 and VH6 heavy chain variable region gene families. Mol Immunol. 1993;30:1601-16. https://doi.org/10.1016/0161-5890(93)90452-H. PMID:8247031.
  • VanDeventer JA, Wittrup KD. Yeast surface display for antibody isolation: Library construction, library screening, and affinity maturation [Internet]. In: Ossipow V, Fischer N, editors. Monoclonal Antibodies. Totowa, NJ: Humana Press. 2014. p. 151-81.
  • Chao G, Lau WL, Hackel BJ, Sazinsky SL, Lippow SM, Wittrup KD. Isolating and engineering human antibodies using yeast surface display. Nat Protoc. 2006;1:755-68. https://doi.org/10.1038/nprot.2006.94. PMID:17406305.
  • Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008;36:503-8. https://doi.org/10.1093/nar/gkn316. PMID:18503082.
  • Sircar A, Kim ET, Gray JJ. RosettaAntibody: Antibody variable region homology modeling server. Nucleic Acids Res. 2009;37:W474-9. https://doi.org/10.1093/nar/gkp387. PMID:19458157.
  • Lefranc MP, Pommié C, Kaas Q, Duprat E, Bosc N, Guiraudou D, Jean C, Ruiz M, Da Piédade I, Rouard M, et al. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. Dev Comp Immunol. 2005;29:185-203. https://doi.org/10.1016/j.dci.2004.07.003. PMID:15572068.